Why Flowserve (FLS) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2231703/why-flowserve-fls-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2231703
Feb 26, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Top Stock Reports for JPMorgan Chase, Salesforce & Vertex Pharmaceuticals
https://www.zacks.com/commentary/2231762/top-stock-reports-for-jpmorgan-chase-salesforce-vertex-pharmaceuticals?cid=CS-ZC-FT-research_daily-2231762
Feb 26, 2024 - Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Salesforce, Inc. (CRM) and Vertex Pharmaceuticals Incorporated (VRTX).
0
Why SkyWest (SKYW) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2231774/why-skywest-skyw-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2231774
Feb 26, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Why Lincoln Electric Holdings (LECO) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2231772/why-lincoln-electric-holdings-leco-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2231772
Feb 26, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Trex (TREX) Q4 Earnings and Revenues Top Estimates
https://www.zacks.com/stock/news/2231982/trex-trex-q4-earnings-and-revenues-top-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2231982
Feb 26, 2024 - Trex (TREX) delivered earnings and revenue surprises of 5.26% and 1.27%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Theravance Biopharma (TBPH) Tops Q4 Earnings and Revenue Estimates
https://www.zacks.com/stock/news/2231988/theravance-biopharma-tbph-tops-q4-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2231988
Feb 26, 2024 - Theravance Bio (TBPH) delivered earnings and revenue surprises of 175% and 0.43%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Why Invesco (IVZ) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2231711/why-invesco-ivz-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2231711
Feb 26, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Why Toll Brothers (TOL) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2232442/why-toll-brothers-tol-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2232442
Feb 27, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Lemonade (LMND) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2232796/lemonade-lmnd-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2232796
Feb 27, 2024 - Lemonade (LMND) delivered earnings and revenue surprises of 22.78% and 2.13%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
SoundThinking (SSTI) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2232780/soundthinking-ssti-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2232780
Feb 27, 2024 - SoundThinking (SSTI) delivered earnings and revenue surprises of -350% and 0.30%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0